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Abstract TheMoonwalker (Mwk) mouse is a recent model of
dominantly inherited cerebellar ataxia. The motor phenotype
of theMwkmouse is due to a gain-of-function mutation in the
gene encoding the cation-permeable transient receptor poten-
tial channel (TRPC3). This mutation converts a threonine into
an alanine in the highly conserved cytoplasmic S4–S5 linker
of the channel, affecting channel gating. TRPC3 is highly
expressed in cerebellar Purkinje cells and type II unipolar
brush cells that both degenerate in the Mwk mouse. Studies
of theMwkmouse have provided new insights into the role of
TRPC3 in cerebellar development and disease, which could
not have been predicted from the Trpc3 knockout phenotype.
Here, the genetic, behavioral, histological, and functional
characterization of the Mwk mouse is reviewed. Moreover,
the relationship of the Mwk mutant to other cerebellar mouse
models and its relevance as a model for cerebellar ataxia are
discussed.
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Introduction
The cerebellar ataxias are a highly heterogeneous group of
neurological disorders that impinge on the cerebellum and its
afferent and efferent connections. Patients affected by cere-
bellar ataxia suffer from poor coordination of movements,
imbalance, and a wide-based unsteady gait. Patients also
exhibit various combinations of oculomotor deficits,
dysarthria, and kinetic tremor. Moreover, patients often pres-
ent with additional extra-cerebellar signs including marked
cognitive dysfunction. Ataxias are rare diseases with a varying
prevalence between 1 and 40:100,000 [1, 2]. The ataxias are
broadly classified into hereditary ataxias, nonhereditary de-
generative ataxias, and acquired ataxias [3, 4]. The hereditary
ataxias comprise a growing list of genetically diverse disor-
ders with over 43 genetic loci known to cause the autosomal
dominant ataxias and altogether more than 100 genes that
primarily cause ataxia when mutated [1–3]. However, there
are still several clinically distinct forms of hereditary ataxias
for which the disease-causing mutations have not been iden-
tified, and additional genes underlying cerebellar ataxia re-
main to be discovered. The vast number of genes implicated in
ataxia suggests that multiple pathogenic pathways can induce
cerebellar dysfunction and atrophy. Indeed, the pathogenesis
of cerebellar ataxia appears to be highly heterogeneous, and a
multitude of potential disease mechanisms have been pro-
posed. Many of these are not ataxia-specific but common
disease features of neurodegenerative disorders in general,
such as oxidative stress, protein aggregation, and transcrip-
tional dysregulation [3, 5]. The challenge remains to better
understand the specific disease-causing mechanisms underly-
ing the complex cerebellar ataxias and to identify common
pathological pathways that could be targeted therapeutically.
Animal models provide invaluable insights into the normal
function of the cerebellum and into the pathogenic mecha-
nisms contributing to cerebellar ataxia. A large number of
mouse mutants exhibiting a cerebellar ataxia phenotype have
been reported (reviewed in [6, 7]). Historically, the first ataxic
mouse models that were intensively investigated were natu-
rally occurring mutants, including the Lurcher (gain-of-func-
tion mutation in Grid2), staggerer (Rora deletion), and
Weavermouse (gain-of-function mutation inGirk2). For some
of these spontaneous mutants, a direct clinical relevance was
demonstrated only years after their initial discovery. For
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example, the mutation in the staggerer mouse was first ob-
served at the Jackson Laboratory in 1955 and later identified
as a null allele of the retinoid acid-related orphan nuclear
receptor-alpha (RORα) [8].More than 40 years after the initial
description of the staggerermouse, expression profiling stud-
ies suggested a mechanistic link between RORα and
spinocerebellar ataxia (SCA) type 1 (SCA1) [9, 10]. Subse-
quently, RORα was shown to physically interact in a regula-
tory transcriptional complex with ATXN1, the mutated pro-
tein in SCA1 [11]. Similarly, it took 59 years after the initial
discovery of the Lurchermutant, until the identification of the
first human mutations in GRID2 in patients with cerebellar
ataxia [12, 13]. These findings underscore the often tedious
search for human genes implicated in the rare cerebellar
ataxias, but also the power of ataxic mouse mutants in dis-
secting the disease-relevant molecular mechanisms of cere-
bellar dysfunction.
In addition to the spontaneous mutants, many transgenic,
knockout, and knockin mouse lines have been engineered for
the human ataxias with varying degrees of success. Some of
these mutants, particularly the generated mouse models of the
trinucleotide-repeat SCAs, phenocopy the human condition
reasonably well and have been valuable tools in analyzing the
underlying molecular pathogenesis and discovering potential
new therapeutics for cerebellar ataxia [14]. Genome-wide
random mouse mutagenesis represents a powerful comple-
mentary approach to gene knockouts and transgenics for the
discovery of novel genes and allelic gene series with func-
tional implications for the central nervous system [15–17].
This phenotype-driven approach has been particularly suc-
cessful in identifying cerebellar mutants, partly due to the
relatively easy detection of motor phenotypes in the mouse.
As part of a large N-ethyl-N-nitrosurea (ENU) mutagenesis
screen to identify new models of human cerebellar ataxia, we
identified the dominantly inheritedMoonwalker (Mwk) mouse
[18]. Here, I review the genetic and functional characterization
of the Mwk mouse, which has provided new insights into the
role of the transient receptor potential (TRP) channel TRPC3
in cerebellar development and disease [18, 19]. I also examine
the relationship of the Mwk mutant to other mouse models of
cerebellar ataxia and its relevance for the human disorder.
TheMwkMouse: Gain-of-FunctionMutation in the Trpc3
Gene
Mwkmice harbor a single non-synonymous point mutation in
exon 7 of the Trpc3 gene located on chromosome 3 [18]. This
gene encodes the TRPC3 channel, a member of the transient
receptor potential (TRP) family of ion channels. The TRP
superfamily constitutes one of the largest ion channel families
and is involved in numerous physiological functions [20, 21].
The mammalian TRP channel proteins form six-
transmembrane cation-permeable channels that are grouped
into six subfamilies including the canonical TRPC family
(TRPC 1–7). TRPC channels are widely expressed in different
mouse tissues including the nervous system, where they func-
tion as non-selective calcium entry channels with distinct
modes of activation [22, 23]. Microarray analysis of more
than 80 different mouse cell lines and tissues shows that
TRPC3 is highly expressed in the nervous system, particularly
in the cerebellum (BioGPS gene portal) (http://Biogps.org).
Notably, it is the alternatively spliced short isoform TRPC3c
that is preferentially expressed in the cerebellum [24]. This
TRPC3 isoform lacks part of the CIRB domain (see Fig. 1b),
which is known to modulate TRPC channel activity via
competitive binding of the inositol triphosphate (IP3)
receptor (IP3R) and calmodulin (CaM), resulting in a channel
with enhanced efficacy due to increased channel-opening
frequency [24]. Within the cerebellum, TRPC3 is most highly
expressed on the soma as well as the dendrites of Purkinje
cells [25, 26] (Fig. 1a). In fact, TRPC3 was shown to be the
most abundant TRP channel in Purkinje cells [25]. In addition
to Purkinje cells, TRPC3 was recently found to be selectively
expressed in type II unipolar brush cells (UBCs), which are
excitatory glutamatergic interneurons in the cerebellum (Fig.
1a) [19]. Using a Trpc3 knockout mouse model, Hartmann
et al. have demonstrated that TRPC3 mediates metabotropic
glutamate receptor subtype 1 (mGluR1)-dependent synaptic
transmission in Purkinje cells [25]. Similarly, activation of
group I mGluR gates TRPC3 channels in type II UBCs [19].
Moreover, TRPC3 was recently suggested to be essential for
the induction of long-term depression (LTD) in cerebellar
Purkinje cells [27]. However, how loss of synaptic function
in the Trpc3 mouse mutants affects LTD remains to be
determined.
The Mwk mutation results in a threonine-to-alanine amino
acid change (T635A; RefSeq# NP_062383)1 in the highly
conserved cytoplasmic S4–S5 linker region of the TRPC3
protein (Fig. 1b). TheMwkmutation does not alter the normal
expression pattern of TRPC3. However, electrophysiological
recordings from Mwk Purkinje cells revealed that mutant
TRPC3 exhibits altered gating properties that promote chan-
nel opening under conditions of low mGluR1 activation [18].
Consistently, Mwk but not wild-type TRPC3 promotes in-
creased calcium signaling and cell death upon overexpression
in neuronal cell lines [18] (unpublished observations). The
molecular mechanisms of how the Mwk mutation leads to
abnormal TRPC3 channel gating remain to be fully elucidat-
ed. One possible mechanismmight be the loss of an inhibitory
phosphorylation by protein kinase C γ (PKCγ). PKCγ has
been shown to inhibit TRPC3 channel activity in overexpres-
sion experiments in heterologous cell lines [28–31]. Indeed,
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threonine 635, which is mutated in the Mwk mouse, has been
shown to be phosphorylated by PKCγ in an in vitro kinase
assay [18]. However, this inhibitory phosphorylation event
has not yet been confirmed in vivo. Moreover, Nelson and
Glitsch have argued that native TRPC3-dependent currents
elicited in cerebellar Purkinje cells are unlikely to be targets of
conventional PKC or PKG kinases in contrast to the findings
observed in overexpression experiments [32]. Alternatively,
the Mwk mutation in the S4–S5 linker might disturb intramo-
lecular interactions within TRPC3 that are important for the
gating mechanism of the channel. This mechanism might be
similar to the established electromechanical coupling in the
structurally related voltage-gated potassium channels, in
which the S4–S5 linker is critical for gating [33]. Recently,
the S4–S5 linker in TRPC4 and TRPC5 channels was identi-
fied as critical constituent of TRPC4/5 channel gating [34],
suggesting a similar key function for the S4–S5 linker in
TRPC3. Future structural studies on TRPC3 and related
TRP channels will undoubtedly shed more light on the intra-
molecular interactions that are crucial for TRPC3 channel
activation and function.
TheMwk Phenotype
From early postnatal days, Mwk mouse mutants display
growth retardation and remain about 60 % the size of their
wild-type littermates throughout life. Homozygous mutants
(Mwk/Mwk) are embryonically lethal. Heterozygous Mwk
mouse mutants display motor and coordination defects from
about 3 weeks of age [18] (Fig. 2). Specifically, Mwk mice
exhibit retropulsion and a wider and “shuffling” gait com-
pared to wild-type littermates. Mwk mice are also severely
impaired in their ability to maintain their balance in the static
rod test. Following their initial behavioral characterization,
Mwk mice are being extensively characterized as part of the
EuroPhenome project [35]. In this large-scale phenotyping
effort, Mwk mutants were found to display significant hyper-
activity, tail elevation, and hind limb grasping behavior, in-
dicative of extra-cerebellar signs. Many other behavioral tests
in the EuroPhenome pipelines are still ongoing.
Notably, the Trpc3 knockout mice also exhibit an ataxic
phenotype, albeit much milder than the Mwk mice [25]. The
fact that both loss and gain of TRPC3 function lead to cere-
bellar ataxia has been previously attributed as “conflicting”
[36]. However, it is commonly observed in other ataxic mouse
mutants as well as human ataxia patients that both decreased
and increased ion channel activities can lead to Purkinje cell
dysfunction and consequently cerebellar ataxia [6, 37]. This
established concept that functionally different mutations in the
same ion channel gene can cause the same disease phenotype
highlights the importance of the associated biological mecha-
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Fig. 1 a TRPC3 mRNA expression in the adult cerebellum. TRPC3 is
predominantly expressed in the Purkinje cell (PC) layer. In addition,
intense labeling of unipolar brush cells (UBCs) in lobules IX and X is
apparent. In situ hybridization image is taken from the AllenMouse Brain
Atlas, available from http://mouse.brain-map.org. bDomain structure and
transmembrane topology of TRPC3. TRPC3 contains four ankyrin-like
repeats at the cytoplasmic N terminus, an N-terminal coiled coil region
and a hydrophobic region, which does not span the plasma membrane
(PM), six transmembrane regions, a pore region, a characteristic TRP
domain in the cytoplasmic C-terminal region, followed by a coiled coil
and truncated calmodulin and IP3R1-binding domain (CIRB). The
localization of the Mwk mutation (T635A) in the cytoplasmic S4–S5
linker region is indicated. Multiple sequence alignment between mouse
mTRPC3, human hTRPC3, and the related mouse mTRPC6 and
mTRPC7 S4–S5 linker shows a high degree of sequence conservation
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Histopathological analysis of the Mwk brain revealed a
slow but progressive loss of Purkinje cells starting at
4 months of age [18] (Fig. 2). Purkinje cell degeneration
is particularly pronounced in the lateral hemispheres of
the cerebellum. Moreover, type II UBCs are dramatically
reduced by 1 month of age [19]. The mode of cell death in
the Mwk cerebellum remains unclear. No evidence of
DNA fragmentation of activation of pro-apoptotic signal-
ing molecules was found, suggesting a cell death mecha-
nism other than apoptosis. Given the underlying gain-of-
function mutation in TRPC3 and observed increase in
calcium signaling, cell death is likely to occur due to
calcium overload. This mechanism might also explain
the fact that type II UBCs are lost much earlier compared
to Purkinje cells in the Mwk cerebellum. Purkinje cells
have an extensive calcium-buffering capacity due to the
presence of high concentrations of calcium-binding pro-
teins including parvalbumin and calbindin. The latter has
been estimated to comprise more than 15 % of total
protein in Purkinje cells [38]. Hence, the ability to handle
an excessive influx of calcium is likely to be much more
rapidly exceeded in UBCs compared to Purkinje cells. It
would be interesting to further dissect the relative contri-
bution of UBC loss and Purkinje cell dysfunction with
regard to the ataxic Mwk phenotype in a conditional
mouse mutant. Type II UBCs are predominantly found
in the vestibulocerebellum, suggesting that their loss in
the Mwk mouse might contribute to the profound balance
impairment of the mutant.
Abnormal Cerebellar Development in theMwkMouse
Significant cerebellar TRPC3 expression starts within the
second postnatal week and peaks at 3 weeks postnatally [18]
(see also Cerebellar Development Transcriptome Database)
(http://www.cdtdb.neuroinf.jp) (Fig. 2), suggesting a role for
this non-selective cation channel during Purkinje cell devel-
opment. Interestingly,Mwk mice exhibit ataxic behavior long
before loss of Purkinje cells is observed (Fig. 2), indicating
that the ataxic phenotype is caused by the dysfunction rather
than the loss of Purkinje cells. Indeed, electrophysiological
alterations are evident in the Mwk Purkinje cells as early as
3 weeks of age [18, 19]. Cell recordings showed that only a
small fraction ofMwk Purkinje cells are spontaneously active
and suggested that Mwk Purkinje cells are generally
depolarized [19]. Consistent with these observations, Mwk
Purkinje cells responded differently to stimulation of
mGluR1, with either no inward current or an inward current
with significantly smaller spikes at a higher frequency [18].
Together, these findings suggest that Purkinje cells in the
developing Mwk cerebellum are profoundly impaired in their
intrinsic and evoked electrophysiological properties.
Developmental abnormalities in the Mwk cerebellum are
also evident in the altered dendritic morphology of the mutant
Purkinje cells. The postnatal increase in TRPC3 expression
coincides with the most intensive phase of dendritic arboriza-
tion of Purkinje cells, suggesting a role for TRPC3 in this
process. Consistent with this idea,Mwk Purkinje cell dendritic
arbors were found to be significantly less elaborate compared
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Fig. 2 Progression of theMwk phenotype from the early postnatal period
until adulthood. TRPC3 expression starts early postnatally and remains
high during adulthood. In situ hybridization images show Trpc3 expres-
sion at P8, P13, P18, and P56. Developing mouse sections are more
laterally compared to themidline section shown for the adult. Importantly,
dendritic abnormalities, Purkinje cell (PC) dysfunction, and overt ataxia
in theMwkmouse appear prior to the onset of PC loss. Calbindin-stained
parasagittal sections from 6-month-old mice are shown. Most of the
unipolar brush cells (UBCs) are lost by 1 month of age; it remains to be
determined when the loss of these neurons starts. Figure modified from
Becker et al. [18].M months,Mwk Moonwalker mouse, P postnatal day,
PC Purkinje cell, UBC unipolar brush cell, WTwild-type
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to wild-type Purkinje cells [18] (Fig. 2). This phenomenon
was particularly apparent in organotypic slice cultures of the
developing cerebellum, where Mwk Purkinje cells exhibit a
profoundly reduced dendritic arbor. This dendritic phenotype
in the Mwk mice that have increased cerebellar calcium sig-
naling is consistent with other studies showing reduced
Purkinje cell dendritic growth upon activation of mGluR1
[39, 40] and PKC [41–43]. Recently, voltage-gated calcium
channels (VGCCs) were implicated in the regulation of
Purkinje cell dendritic growth after chronic mGluR1 or PKC
activation [44]. Interestingly, genetic knockout of Trpc3 or
pharmacological inhibition of TRPC3 did not alter Purkinje
cell dendritic arborization [44]. Together, these findings sug-
gest that it is the excessive calcium influx during the critical
period of dendritic development in Mwk mice that causes
inhibition of dendritic growth. The inhibition of Purkinje cell
dendritic arborization by increased calcium signaling through
activation of mGluR1, TRPC3, and PKC might be a powerful
negative feedback mechanism to limit the size of the dendritic
arbor after the establishment of a sufficient number of granule
cell parallel fiber contacts. This model is consistent with
earlier findings that electric activity controls Purkinje cell
dendritogenesis [45]. In further support of this, Purkinje cells
of the Lurcher mouse with a gain-of-function mutation in the
δ2 glutamate receptor (GluD2), which changes the receptor
into a leaky membrane channel resulting in chronic depolar-
ization, also exhibit profoundly impaired dendritic growth
[46].
An extensive literature supports a role for calcium signal-
ing in the dendritic morphogenesis of neurons including the
local regulation of dendritic branch dynamics as well as the
global control of gene transcription (reviewed in [47, 48]).
However, surprisingly, little is known about the specific
calcium-activated signaling mechanisms that regulate
Purkinje cell dendritic arborization downstream of mGluR1,
TRPC3, and VGCCs. PKCs have emerged as one of the
kinases that regulate Purkinje cell dendritic arborization in
response to increased calcium influx (reviewed in [43, 49]).
It appears that both PKC isoforms, PKCα and PKCγ, con-
tribute to Purkinje cell dendritic development, depending on
the strength of the stimulus. Furthermore, calmodulin-
dependent kinases (CaMKs) have been implicated in Purkinje
cell dendritic growth. Pharmacological block of CaMKs has
been reported to reduce the number of Purkinje cell primary
dendrites in cerebellar cultures [50]. This effect was only
observed between 5 and 15 days in vitro but not later, sug-
gesting that CamKs might be involved in the early phases of
Purkinje cell dendritogenesis and before a critical function of
TRPC3 in this process. The specific substrates of PKCs and
CamKs that regulate Purkinje cell dendritic development re-
main largely unknown. The only reported downstream effec-
tor of CamKII signaling in Purkinje cells controlling local
dendritic branching is the microtubule destabilizer stathmin,
which is phosphorylated by CamKII upon activation of
VGCCs and mGluR1 [51]. Thus, further studies are needed
to dissect the molecular mechanisms that control the calcium-
dependent Purkinje cell dendritic growth during development.
TheMwk mouse provides an excellent model system to study
the transcription-dependent and transcription-independent ef-
fector pathways that regulate the developmental dendritic
arborization of Purkinje cells. Efforts are underway to identify
the genes and pathways that mediate Purkinje cell dendritic
growth upon TRPC3 activation. Importantly, as Purkinje cells
constitute significantly less than 1 % of the total cerebellar cell
population [52], Purkinje cell-specific transcriptional and bio-
chemical profiling requires enriched cell preparations obtain-
ed by cell sorting or laser microdissection [53, 54].
The Relevance of TRPC3 Signaling for Cerebellar Ataxia
Mouse knockout studies have demonstrated a key role for
TRPC3 in mediating mGluR1-dependent synaptic transmis-
sion in Purkinje cells [25]. In the molecular layer, Purkinje
cells receive major glutamatergic input from granule cell
parallel fibers. Glutamate released from the parallel fiber
presynaptic terminals binds to AMPA receptors and
mGluR1 at the parallel fiber-Purkinje cell synapse (Fig. 3).
Influx of sodium ions through AMPA receptor channels leads
to a rapid postsynaptic depolarization, whereas mGluR1s
mediate a local dendritic calcium signal and a prolonged
depolarization known as slow excitatory postsynaptic current
(slow EPSC) (reviewed in [55]). Glutamate binding to
mGluR1 activates phospholipase C (PLC) via G protein
Gαq to produce IP3 and diacylglycerol (DAG). IP3 subse-
quently activates calcium-permeable IP3R1 receptor channels
on the endoplasmic reticulum (ER) membrane, resulting in a
characteristic local dendritic calcium response that is required
for the induction of LTD [56]. The mGluR1-dependent slow
EPSC is mediated by TRPC3 [25]. The exact gating of
TRPC3 following of mGluR1 activation remains to be eluci-
dated but might involve Rho GTPase-dependent activation of
phospholipase D1 (PLD1) [57] as well as IP3R and calmod-
ulin [58] and others (reviewed in [59, 60]). TRPC3 activity
has been proposed to be negatively regulated through phos-
phorylation by PKCγ and perhaps other kinases [28–31, 59],
but the exact nature of this inhibitory phosphorylation remains
controversial [32].
Importantly, disruption of any component of the mGluR1-
triggered signaling cascade results in cerebellar dysfunction
and disease. Similar to the Mwk mouse phenotype, knockout
mice deficient in the genes encoding mGluR1 [61, 62], Gαq
[63], IP3R1 [64], TRPC3 [25], and PKCγ [65] all exhibit
cerebellar ataxia. Moreover, auto-antibodies against mGluR1
are associated with neoplastic as well as subacute cerebellar
ataxia in human patients [66–68]. Also, deletions in the ITPR1
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gene encoding IP3R1 cause SCA15 [69]. Gain-of-function
missense mutations in the PRKCG gene encoding PKCγ
cause SCA14 [70]. Interestingly, SCA14-associated PKCγ
mutants were shown to fail to phosphorylate TRPC3, resulting
in a sustained calcium influx that might be central to the
SCA14 pathogenesis [30]. Thus, the Mwk mouse might rep-
resent a relevant model for SCA14. Overexpression of
SCA14-associated PKCγ mutations in developing Purkinje
cells also disturbs their dendritic development [71], which is
consistent with the Mwk developmental phenotype.
Recently, activation of mGluR1 was shown to also trigger
gating of the postsynaptic GluD2 receptor [72]. In another
study, GluD2 was found to associate with a mGluR1-TRPC3-
PKCγ signaling complex and to regulate mGluR1-mediated
synaptic transmission in cerebellar Purkinje neurons [73].
Interestingly, in this study, genetic loss of GluD2 was found
to increase extra-synaptic mGluR1 and TRPC3 expression in
the hotfoot mutant mice, resulting in abnormal synaptic trans-
mission. Both loss-of-function and gain-of-functionmutations
in theGrid2 gene encodingGluD2 result in defects in Purkinje
cell dendritic arborization and cerebellar ataxia [6]. Recently,
the first mutations in the human GRID2 gene have been
reported in patients with cerebellar ataxia [12, 13].
In addition to the direct links between disrupted gluta-
matergic signaling and cerebellar ataxia described above,
increasing evidence points towards a role of perturbed TRPC3
signaling in other genetic forms of cerebellar ataxia. For
example, the expression of TRPC3 and other genes involved
in calcium homeostasis was shown to be downregulated in a
mouse model of SCA1 [74]. Importantly, these expression
changes occurred early and before any observed pathological
changes in SCA1, suggesting that they might be a causal
factor in the pathogenesis of SCA1. Consistent with these
findings, mGluR1-TRPC3-mediated synaptic signaling is
disrupted in homozygous staggerer mice, an extreme model
of SCA1 [75]. Both expression of mGluR1 and TRPC3 were
found to be dramatically reduced in these mice, and conse-
quently, slow EPSCs were absent. Similarly, mGluR1-
mediated synaptic transmission is completely absent in a
transgenic mouse model of SCA3 [76].
Collectively, these studies underscore that TRPC3 is a
central player in a glutamate-triggered signaling cascade that
is vital for Purkinje cell function and, when disrupted, results
in cerebellar disease inmice andmen (Fig. 3).Moreover, these
findings suggest that TRPC3 itself might be a promising
candidate gene for human cerebellar ataxia. Supporting this,
a methylation-regulating TRPC3 promoter polymorphismwas
found to be enriched in patients with idiopathic cerebellar
ataxia [77]. So far, candidate screening of the TRPC3 gene
did not identify potential mutations in patients with sporadic
late-onset cerebellar or episodic ataxia, suggesting that
TRPC3 mutations are unlikely to be a common cause of
cerebellar ataxia [78]. However, TRPC3 mutations might still
contribute to cerebellar ataxia in specific subtypes of the
disease that have not been screened yet. The increasing use
of next-generation sequencing approaches for the genetic
diagnosis of cerebellar ataxia is poised to fully elucidate the
role that TRPC3 mutations may play in human cerebellar
ataxia [79].
Conclusions
The gain-of-functionMwk mouse has provided novel insights
into the function of TRPC3 in the normally developing cere-
bellum as well as in cerebellar ataxia. In particular, the link
between TRPC3-triggered aberrant Purkinje cell development
and cerebellar ataxia could not have been predicted from the
Trpc3 knockout phenotype, underscoring the power of
genome-wide random mouse mutagenesis in identifying im-
portant mechanisms underlying nervous system dysfunction.
Accumulating evidence from other cell- and animal-based
models of cerebellar ataxia suggests that abnormal Purkinje
cell development and early changes in Purkinje cell physiol-
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Fig. 3 mGluR1-TRPC3 signaling at parallel fiber-Purkinje cell synap-
ses. TRPC3 is central to the glutamate-triggered pathway that is vital for
Purkinje cell function and, when disrupted, results in cerebellar ataxia.
Please see main text for details. AMPAR AMPA receptor, GluD2 δ2
glutamate receptor, IP3R1 inositol triphosphate receptor type 1, mGluR1
metabotropic glutamate receptor subtype 1, PKC protein kinase C, PLC
phospholipase C, PLD phospholipase D, TRPC3 transient receptor po-
tential channel C3
challenging on our view of cerebellar ataxia as a neurodegen-
erative disorder [11, 71, 80, 81].
Despite major progress in deciphering the genetic and
molecular mechanisms of cerebellar ataxia, effective therapies
for this group of neurological diseases are still lacking. One of
the biggest challenges of ataxia research is the identification of
drug targets and the development of novel therapeutic ap-
proaches. The Mwk mouse and other cerebellar mutants have
highlighted the importance of synaptic transmission at the
parallel fiber-Purkinje cell synapse and thus mGluR1-
TRPC3 signaling in cerebellar function and disease. Indeed,
abnormal mGluR1-TRPC3 signaling seems to be a unifying
feature of many hereditary ataxias including the more com-
mon trinucleotide expansion disorders SCA1 and SCA3.
Thus, pharmacological regulation of this pathway might be
beneficial not only in one particular ataxia subtype but in a
larger group of ataxias that share a common pathological
mechanism. Modulating mGluR1-TRPC3 signaling in cere-
bellar ataxia is particularly attractive, as it would target neu-
ronal dysfunction early on during the course of the disease.
Given the importance of the TRPC3 pathway in cerebellar
ataxia, theMwkmouse promises to be a valuable model to test
novel compounds that might be beneficial in human cerebellar
ataxia. The TRPC3 channel itself might be an attractive target
to modulate in cerebellar ataxia. Hopefully, more selective and
potent pharmacological modulators of TRPC3 will be devel-
oped in the near future that could hold great promise as
therapeutic agents for cerebellar ataxia.
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